GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ibnsina Pharma (CAI:ISPH) » Definitions » Scaled Net Operating Assets

Ibnsina Pharma (CAI:ISPH) Scaled Net Operating Assets : 0.31 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Ibnsina Pharma Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Ibnsina Pharma's operating assets for the quarter that ended in Mar. 2024 was E£19,713 Mil. Ibnsina Pharma's operating liabilities for the quarter that ended in Mar. 2024 was E£14,037 Mil. Ibnsina Pharma's Total Assets for the quarter that ended in Dec. 2023 was E£18,550 Mil. Therefore, Ibnsina Pharma's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.31.


Ibnsina Pharma Scaled Net Operating Assets Historical Data

The historical data trend for Ibnsina Pharma's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibnsina Pharma Scaled Net Operating Assets Chart

Ibnsina Pharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only 0.15 0.12 0.20 0.42 0.41

Ibnsina Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.33 0.34 0.28 0.31

Competitive Comparison of Ibnsina Pharma's Scaled Net Operating Assets

For the Medical Distribution subindustry, Ibnsina Pharma's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ibnsina Pharma's Scaled Net Operating Assets Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ibnsina Pharma's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Ibnsina Pharma's Scaled Net Operating Assets falls into.



Ibnsina Pharma Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Ibnsina Pharma's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(17419.084-12164.989)/12863.793
=0.41

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=18549.811 - 1130.727
=17419.084

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=17100.691 - 1176.434 - 3759.268
=12164.989

Ibnsina Pharma's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Dec. 2023 )
=(19712.854-14036.93)/18549.811
=0.31

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=20655.087 - 942.233
=19712.854

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=19107.956 - 853.797 - 4217.229
=14036.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ibnsina Pharma Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Ibnsina Pharma's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Ibnsina Pharma (CAI:ISPH) Business Description

Traded in Other Exchanges
N/A
Address
Industrial zone 1, PO box 91, Obour, EGY
Ibnsina Pharma is an Egypt based pharmaceutical distribution company. It is engaged in purchasing and selling in wholesale and distribution of pharmaceutical, semi- pharmaceutical and cosmetic products. It distributes a portfolio of pharmaceutical products from local and multinational pharmaceutical companies to retail pharmacies, wholesalers, hospitals, and public health institutions. In addition, the company also offers services including warehousing and logistics, marketing solutions, importation, and packaging, market research, and analysis.

Ibnsina Pharma (CAI:ISPH) Headlines

No Headlines